PlainPharmaWatch

CMS Open Payments · Program Year 2024

Astellas Pharma Inc

Astellas Pharma Inc reported $6,891,256.85 in payments to 81 physicians and teaching hospitals across 2,831 transactions.

See the rankings → How this is sourced
$6.9M
Total payments
2,831
Transactions
81
Recipients
+$11.9K
General Payments vs PY2023

Astellas Pharma Inc reported $6,891,256.85 in payments to 81 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #223 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $85.1K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Astellas Pharma Inc pairs top-quartile payment volume with a moderately concentrated payment pattern.

#223
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Astellas Pharma Inc's CMS-reported General Payments increased by $11.9K (+16.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ASTELLAS PHARMA INCPY2023: ASTELLAS PHARMA INCPY2024: Astellas Pharma Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$70.8KPY2024$82.8K
PY2023
$70,836.45
PY2024
$82,764.91

How Astellas Pharma Inc ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Astellas Pharma Inc's total vs. every reporting company

CMS Open Payments, Program Year 2024

$6,891,257 Top 12% higher than 88% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Astellas Pharma Inc

$6,891,256.85: that is what Astellas Pharma Inc reported in payments to 81 physicians and teaching hospitals during Program Year 2024, spread across 2,831 transactions ($2.4K per transaction, $85.1K per recipient). The company sits at rank #223 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 4 general-payment categories charted below, "Travel and Lodging" is the largest at $51.9K across 20 transactions, 0.8% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Astellas Pharma Inc made 4 types of general payments. "Travel and Lodging" is the largest category at $51.9K, 0.8% of the company's reported total.

How Astellas Pharma Inc divides its payments

How the reported total splits across payment categories

1. Travel and Lodging$51.9K2. Compensation for Services…$21.2K3. Consulting Fee$5.8K4. Food and Beverage$3.9K
Payment Type Amount Transactions
Travel and Lodging $51.9K 20
Compensation for Services Other Than Consulting $21.2K 9
Consulting Fee $5.8K 7
Food and Beverage $3.9K 45

Recipient Concentration in General Payments

The five largest recipient relationships account for $73,221.75 (88.5%) of $82,764.91 in this company's General Payments records across 36 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Astellas Pharma Inc

The five named recipients with the highest reported General Payments from this company

Mark Levis$26.2KSandip Vasavada$21.2KTerence Friedlander$20.6KLinda Cripe$3.5KNaval Daver$1.7K
  1. 1

    Mark Levis

    $26,221.48 across 9 reported transactions

  2. 2

    Sandip Vasavada

    $21,158.17 across 4 reported transactions

  3. 3

    Terence Friedlander

    $20,630.87 across 14 reported transactions

  4. 4

    Linda Cripe

    $3,520.00 across 4 reported transactions

  5. 5

    Naval Daver

    $1,691.23 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $2.4K. Average per recipient: $85.1K.

Total Amount

$6,891,256.85

Avg per Transaction

$2.4K

Avg per Recipient

$85.1K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Astellas Pharma Inc Share

0.0%

#223 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Astellas Pharma Inc

Astellas US Technologies

$6.9M 0 recipients

Dompe Farmaceutici S.p.A.

$6.9M 7 recipients

Johnson & Johnson Vision Care, Inc.

$6.8M 29,358 recipients

Aptis Medical, LLC

$6.8M 95 recipients

Woven Orthopedic Technologies, LLC

$7.0M 11 recipients

Neurology Practice Consortium Gpo, LLC

$7.0M 0 recipients

Frequently Asked Questions

How much did Astellas Pharma Inc pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Astellas Pharma Inc, totaling $6,891,256.85 across 2,831 transactions to physicians and hospitals.
How many physicians received payments from Astellas Pharma Inc? ▾
Averaging $85.1K per recipient, Astellas Pharma Inc's 2024 payments reached 81 physicians and teaching hospitals.
What types of payments did Astellas Pharma Inc make? ▾
Astellas Pharma Inc made 4 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Travel and Lodging" at $51.9K, representing 0.8% of the company's reported total.
How does Astellas Pharma Inc rank among pharmaceutical companies? ▾
By total payment amount, Astellas Pharma Inc sits at #223 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Astellas Pharma Inc? ▾
The average transaction from Astellas Pharma Inc was $2.4K in 2024. The company made 2,831 total transactions to 81 recipients.
Where does the payment data for Astellas Pharma Inc come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Astellas Pharma Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.